Even with the launch of a third FDA-approved PEP in mid-July, the ZENPEP franchise has continued to gain share at an impressive pace, and we are especially pleased by the positive feedback from physicians and patients regarding ZENPEP's ability to control the signs and symptoms of EPI, in particular for those patients who have switched from other PEPs, Faherty said.